- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03512925
Effects of a Standardized Post-coercion Review Session.
Effects of a Standardized Post-coercion Review Session on Objective and Perceived Coercion
The present study aims at exploring the impact of a standardized post-coercion review session of coercive measures that took place in the psychiatric inpatient setting in reducing the use of coercive measures and the subjective perception of coercion. It is well known that coercive measures have a major negative impact on the health, well-being and the course of treatment of patients suffering from mental health issues. Many interventions have been implemented in the last years to reduce the use of coercion and limit its consequences.
The investigators developed a standardized post-coercion review intervention. This session takes place as soon as possible after the concerned coercive measure and is moderated by a member of staff who has not been involved in the use of coercion. Other persons involved are the patient, a staff member who took the decision leading to the use of the coercive measure, and a one of the patient's relatives.
Hypothesis is that the use of this standardized intervention can reduce the use of subsequent coercive measures and level of perceived coercion, prevent the development of post-traumatic symptoms, help preserving a trustful therapeutic relationship and positively change the attitude of staff regarding the use of coercion. This intervention has been proven to be well accepted by patients and staff members in a previous pilot study.
The present study is designed as a randomised-controlled study investigating the effect of post-coercion review.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The present study aims at exploring the impact of a standardized post-coercion review session of coercive measures that took place in the psychiatric inpatient setting in reducing the use of coercive measures and the subjective perception of coercion. It is well known that coercive measures have a major negative impact on the health, well-being and the course of treatment of patients suffering from mental health issues. Many interventions have been implemented in the last years to reduce the use of coercion and limit its consequences.
The investigators developed a standardized post-coercion review intervention. This session takes place as soon as possible after the concerned coercive measure and is moderated by a member of staff who has not been involved in the use of coercion. Other persons involved are the patient, a staff member who took the decision leading to the use of the coercive measure, and a one of the patient's relatives. The guidelines define important themes and questions that should be addressed during the review session. These guidelines have been developed with the help of psychiatrists, nurses and a peer worker.
Hypothesis is that the use of this standardized intervention can reduce the use of subsequent coercive measures and level of perceived coercion, prevent the development of post-traumatic symptoms, help preserving a trustful therapeutic relationship and positively change the attitude of staff regarding the use of coercion. This intervention has been proven to be well accepted by patients and staff members in a previous pilot study. The methods combine quantitative and qualitative evaluations.
The present study is designed as a randomised-controlled study investigating the effect of post-coercion review.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 12351
- Vivantes Klinikum Neukölln
-
Berlin, Germany, 10967
- Vivantes Klinikum Am Urban
-
Berlin, Germany, 12099
- Vivantes Wenckebach-Klinikum
-
Berlin, Germany, 12526
- Alexianer Krankenhaus Hedwigshöhe
-
Berlin, Germany, 13088
- St. Joseph Krankenhaus Weißensee
-
-
Berlin
-
Berlin-Mitte, Berlin, Germany, 10115
- Psychiatrische Universitätsklink der Charité - SHK
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inpatient
- Subject to coercive measure (seclusion, restraint, forced medication)
- Diagnosis of a psychotic disorder (ICD-10: F1x.5, F2x, F31.x).
- Written and informed consent.
Exclusion Criteria:
- Inability to provide informed consent
- Hospital stay < 24h
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Standardized post-coercion review
Intervention: Standardized post-coercion review session.
Patients allocated to this arm receive a standardized post-coercion review of the coercive measure they experienced using the developed guidelines.
|
Debriefing session following the developed guidelines including setting and themes.
|
|
No Intervention: Control group
Patients allocated to this arm are treated following usual standards and routine.
This might include some form of post-coercion review that doesn't follow the developed standardized guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective coercive measures
Time Frame: At the time of discharge from the hospital by every included patient, up to 6 months
|
Number of coercive measures (seclusion, restraint, forced medication)
|
At the time of discharge from the hospital by every included patient, up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective experience of coercion (1)
Time Frame: At the time of discharge from the hospital by every included patient, up to 6 months
|
Subjective experience coercion assessed by the German version of the Perceived Coercion Subscale (PCS) of the MacArthur Admission Experience Survey (AES).
The AES comprises 16 dichotomous items (yes-no answers) divided in 4 subscales.
The PCS comprises 5 items.
A higher score (range 0-5) indicates a high level of perceived coercion.
|
At the time of discharge from the hospital by every included patient, up to 6 months
|
|
Subjective experience of coercion (2)
Time Frame: At the time of discharge from the hospital by every included patient, up to 6 months
|
Subjective experience coercion assessed by the Coercion Ladder (CL).
The CL is an analog scale ranging from 1 to 10 and assessing the level pf perceived coercion.
Higher values indicate a higher level of perceived coercion.
|
At the time of discharge from the hospital by every included patient, up to 6 months
|
|
Subjective experience of coercion (3)
Time Frame: At the time of discharge from the hospital by every included patient, up to 6 months
|
Subjective experience coercion assessed by the German version of the Coercion Experience Scale (CES).
The CES is a scale used to measure the impact of coercive measures.
It comprises 29 items related to perceived stressors during a coercive intervention with a 5-point Likert-scale.
A total score is used with higher values indicating higher perceived coercion.
|
At the time of discharge from the hospital by every included patient, up to 6 months
|
|
Quality of the therapeutic relationship
Time Frame: At the time of discharge from the hospital by every included patient, up to 6 months
|
Evaluation of the quality of the therapeutic relationship assessed by the German version of the Work Alliance Inventory-Short Form (WAI-SR).
The WAI comprises 12 items divided into 3 subclass (goal, task, bond).
each subscale comprises 4 items with a 5-point Likert-scale.
The score range for each subscale ranges from 5 to 20.
Higher scores indicate a better therapeutic alliance.
|
At the time of discharge from the hospital by every included patient, up to 6 months
|
|
Post-traumatic symptoms (1)
Time Frame: At the time of discharge from the hospital by every included patient, up to 6 months
|
Development of post-traumatic symptoms assessed by the German version of the Peri-Traumatic Distress Inventory (PDI).
The PDI assesses the reactions during the traumatic event.
It comprises 13 items with a 0-4 Likert-scale.
Scores of all items are summed up and so the total score ranges from 0 to 52.
A score higher than 26 indicates a high risk of developing a post traumatic stress disorder.
|
At the time of discharge from the hospital by every included patient, up to 6 months
|
|
Post-traumatic symptoms (2)
Time Frame: At the time of discharge from the hospital by every included patient, up to 6 months
|
Development of post-traumatic symptoms assessed by the German version of the Impact of Events Scale Revised (IES-R).
The IES-R comprises 22 items with a Likert-scale ranging from 0 to 5. Items are divided into 3 sub scales (Intrusion (7 items), Avoidance (8 items), and Hyperarousal (7 items)).
Scores for each sub scales are built by adding the answers to each item.
Higher scores indicate a higher level of symptoms.
The probability of post traumatic stress disorder (PTSD) is assessed using a formula developed by the German translators: X = (-0,02 x intrusion) + (0,07 x avoidance) + (0,15 x hyperarousal) - 4,36.
Scores >0 indicate the probable presence of PTSD.
|
At the time of discharge from the hospital by every included patient, up to 6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: PD Dr. med. Montag, Charité
- Study Chair: Dr. med. Mahler, Charité
- Principal Investigator: Dr. med. Wullschleger, Charité
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NBZM_MZ
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coercive Measures
-
Centre Hospitalier Intercommunal Robert BallangerNot yet recruiting
-
University of RochesterAmerican Cancer Society, Inc.Completed
-
Braincare LimitedNot yet recruiting
-
Danat Al Emarat HospitalActive, not recruitingOutcome MeasuresUnited Arab Emirates
-
Shalvata Mental Health CenterGeha Mental Health CenterUnknownPsychotherapy Research and Outcome Measures
-
B.Well Swiss AGEuropean Cardiovascular Research CenterNot yet recruitingVolunteers | Study Focus: Blood Pressure Measures
-
Manuela EicherRecruitingPatient Reported Outcome Measures | Patient SafetySwitzerland
-
Mead Johnson NutritionUniversity of Kansas Medical CenterCompletedBehavioral Measures of ToleranceUnited States
-
US Department of Veterans AffairsCompletedOutcomes | Health Status Measures | Continuous Quality ImprovementUnited States
-
University of Alabama at BirminghamCompletedFasting Blood Measures | Body ScansUnited States